Dexamethasone and hypoglycemia

In a 40-day-old infant with bronchopneumonia and hypoglycemia, Solu-Cortef (hydrocortisone) is generally preferred over Decadron (dexamethasone) if corticosteroid therapy is indicated.

…
Why Solu-Cortef (Hydrocortisone) is preferred:

1. Glucocorticoid vs. Mineralocorticoid Balance:

   • Hydrocortisone has both glucocorticoid and mineralocorticoid activity.

   • In neonates and young infants, especially in the setting of hypoglycemia, adrenal insufficiency or relative adrenal insufficiency should be considered.

   • Mineralocorticoid effect helps support blood pressure and glucose regulation.

   • Dexamethasone has almost no mineralocorticoid activity and is long-acting, which increases the risk of adrenal suppression.

2. Shorter Half-life:

   • Hydrocortisone has a shorter half-life, allowing better control and tapering if needed.

   • Safer in neonates who may need dynamic adjustment.

3. Better mimic of endogenous cortisol:

   • Hydrocortisone closely resembles the body’s natural cortisol, making it more suitable in critical illness or stress-related conditions in neonates.